1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Key Pharma News 30 NOVEMBER 2015

Key Pharma News 30 NOVEMBER 2015

  • November 2015
  • -
  • Espicom Business Intelligence
  • -
  • 27 pages

Industry Trend Analysis - US Filing Underlines Amgen's Biosimilar Market Leader Ambitions
Industry Trend Analysis - Universal HCV Treatment Access To Drive Down Burden
Industry Trend Analysis - Pfizer Laying Strong Foundations For Long-Term Oncology Growth
Industry Trend Analysis - Next Steps Will Be Crucial Following Mylan/Perrigo Merger Rejection
Industry Trend Analysis - Shire Shifting Focus To Rare Diseases
Industry Trend Analysis - Stada's Other Key Markets Will Compensate For Continued Russia Woes
Industry Brief - Merck Completes Sigma-Aldrich Acquisition
Industry Brief - Horizon Withdraws Offer To Acquire Depomed
Industry Trend Analysis - Hikma And Xellia Will Both Profit From Acquisition Agreement
Industry Trend Analysis - Fast Evolving NSCLC Market Limits Portrazza Impact
Industry Brief - EC Approves Genvoya
Industry Brief - Opdivo Expands Indications In US/Aligns EU Brandname
Industry Brief - Kyprolis Gains EU Approval For Combination Use In Relapsed MM
Industry Trend Analysis - Clovis Rociletinib Slip Solidifies AstraZeneca's Position
Industry Brief - Appellate Court Deals Cubicin Blow To Merck
Industry Brief - Court Delivers Palonosetron Blow To Teva
Industry Brief - Sandoz' Third Biosimilar Application Accepted By The FDA
Industry Trend Analysis - Crowded MM Market Will Provide Challenge For Ninlaro
Industry Trend Analysis - Samsung Bioepis Set To Win EU Biosimilar Etanercept First-To-Market Race
Industry Brief - Novartis' Entresto Receives EU Approval For HFrEF
Industry Trend Analysis - Ionsys Will Provide Significant Competitive Edge For The Medicines Company
Industry Trend Analysis - Early Adoption Of Open Innovation To Set Companies Apart
Industry Trend Analysis - Merck To Join Gilead Challengers
Industry Trend Analysis - SLE Market Set To Develop
Industry Trend Analysis - Amgen A Leader In Race For Biosimilar RA Market
Industry Trend Analysis - AS And PsA Approvals In Europe Leave Cosentyx Poised To Dominate
Industry Trend Analysis - Dementia Research Will See Large Increases In Investment

Table Of Contents

Key Pharma News 30 NOVEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Laboratory Products Purchasing Trends, 2016–2017

Global Laboratory Products Purchasing Trends, 2016–2017

  • $ 6000
  • Industry report
  • December 2016
  • by Frost & Sullivan

An End-user Perspective on the Purchasing Process, Product Budgets, and Top Companies for Laboratory Products Readers of Lab Manager Magazine were invited to participate in an online survey in July 2016. ...

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

Biosimilars Market by Product, Manufacturing, Application - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

Biosimilars Market by Product (Recombinant Non-glycosylated Proteins (Insulin, rHGH, Interferon), glycosylated (mAb, EPO), Peptides (Glucagon, Calcitonin)), Manufacturing (In-House, CM0) & Application ...

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

PEGylated Proteins Market by Consumables, Services, Protein Type, Application, End-User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • November 2016
  • by MarketsandMarkets

The global PEGylated proteins market is expected to USD 1,137.8 million by 2021 from USD 690.6 million in 2016, at a CAGR of 10.5% between 2016 and 2021. The growth of this market is mainly driven by increase ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.